What are the long-term outcomes of clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions?
A 2008 study of Brar et al. found that long-term outcomes of clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions were associated with increased rates of target lesion revascularization and stent thrombosis. They concluded that there is a need for larger, randomized studies to fully understand the role of clopidogrel duration and stent type in this population.